Background: Pneumatic injections of non-cross-linked hyaluronic acid are effective in skin rejuvenation, however, the associated biophysical parameters and appearance have not been evaluated. Objectives: To determine the changes in skin biophysical parameters after facial pneumatic injections of non-cross-linked hyaluronic acid. Patients and methods: Twenty-eight healthy female volunteers received pneumatic injections of non-cross-linked hyaluronic acid into the face for consecutive 5 weeks. Skin biophysical parameter assessment and clinical evaluation were performed using the CK Multi-Probe Adapter and Visia system. Five of the volunteers also underwent retroauricular skin biopsy before and after the last treatment. The skin tissues were all stained with Masson-trichrome, Verhoeff-van Gieson stain, and hematoxylin-eosin to evaluate the changes in collagen, elastic fibers, and the epidermis, before and after the last treatment. Results: Transepidermal water loss was significantly lower in week 4 (18.46 ± 4.70 g/h/m2) than at the baseline (22.03 ± 7.15 g/h/m2, p < 0.05). Skin texture was better in week 4 (599.29 ± 354.32) than at the baseline (668.43 ± 342.55, p < 0.05). Skin pores also improved significantly at week 4 (934.07 ± 458.78) compared to the baseline (1024.57 ± 415.31, p < 0.05). Skin wrinkles were improved at the 3-month follow-up (29.29 ± 11.11) compared to the baseline (35.83 ± 16.05, p < 0.05). Conclusion: Pneumatic injections of non-cross-linked hyaluronic acid improved skin TEWL, texture, pores, and wrinkles.
Hyperkeratosis of the nipple and areola is an uncommon dermatosis without well-defined etiology, which occurs mostly in young women and may only be a cosmetic problem. In 1938, Levy-Frankel classified this disease into three variants; type I involves hyperkeratosis with an epidermal nevus, and has rarely been reported. We report a case of a 23-year-old woman with long-term bilateral pigmentation and thickening of the nipples and areolae, accompanied with dark brown, flat lesions with a linear distribution on her left forearm. The verrucous plaques were asymptomatic and could be scratched off by the patient herself. Consequently, she did not seek medical care for more than ten years. The prevalence of this condition is likely underestimated because many affected individuals are not sufficiently motivated to seek medical attention.
Background: Psoriasis is an immune‐mediated skin disease, of which plaque psoriasis is the predominant form. This study aimed to understand the clinical characteristics of patients with moderate‐to‐severe plaque psoriasis who received systemic medications in a real‐world setting in China. Methods: In this retrospective observational study, patients with moderate‐to‐severe plaque psoriasis were identified in electronic medical record databases from two study centers in China between January 1, 2018, and December 31, 2021. Analyses were conducted on patients with a follow‐up period of ≥ 6 months. Primary objectives were to describe demographics, clinical characteristics, treatment experiences, and patterns of systemic treatments among this population. Secondary objectives were to describe healthcare resource utilization. Results: Among 1102 eligible patients included in the systemic treatment analysis set, the mean (standard deviation [SD]) age was 44.9 (14.6) years, and 77% of patients were male. The most common comorbidity was allergic disease and skin disease (11%). Most patients received conventional systemic medications (84%), while few received biologic treatments (16%); 88% of patients discontinued systemic treatments within 90 days of the last prescription, 6% switched to a new systemic medication. The mean (SD) number of visits per patient‐year was 6.5 (5.2) for outpatient and 0.9 (not applicable [NA]) for inpatient. The mean (SD) duration of inpatient visits per patient‐year was 9.3 (NA) days, with a mean (SD) monthly direct medical cost of CYN 371.09 (741.56). Conclusions: These results provide valuable insights for guiding decision‐making for patients with plaque psoriasis. The high treatment discontinuation rate reflects a challenge to disease management and suggests better treatment options are needed for this patient population in China.